Alvotech (ALVO) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $3.85 (-9.08%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Dec 8, 2025 | Glen Santangelo | Barclays | $5.00 | +30.0% |
| Nov 4, 2025 | Niall Alexander | Deutsche Bank | $8.00 | +108.1% |
| May 24, 2024 | Balaji Prasad | Barclays | $22.00 | +472.2% |
| May 21, 2024 | Balaji Prasad | Barclays | $20.00 | +420.2% |
| Jan 29, 2024 | Balaji Prasad | Barclays | $17.00 | +342.1% |
| Jul 1, 2022 | Emmanuel Papadakis | Deutsche Bank | $10.00 | +160.1% |
Top Analysts Covering ALVO
ALVO vs Sector & Market
| Metric | ALVO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.40 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +105.0% | +11474.9% | +17.1% |
| P/E Ratio | 1596.15 | 2.43 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $102M | $132M | $175M | 3 |
| 2026-09-30 | $131M | $161M | $197M | 1 |
| 2026-12-31 | $181M | $221M | $271M | 2 |
| 2027-03-31 | $140M | $171M | $210M | 1 |
| 2027-06-30 | $144M | $176M | $216M | 2 |
| 2027-09-30 | $162M | $198M | $243M | 2 |
| 2027-12-31 | $136M | $166M | $204M | 1 |
| 2028-12-31 | $940M | $957M | $975M | 4 |
| 2029-12-31 | $1.11B | $1.19B | $1.29B | 3 |
| 2030-12-31 | $1.18B | $1.26B | $1.38B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.03 | $-0.02 | $-0.02 | 1 |
| 2026-09-30 | $-0.03 | $-0.02 | $-0.02 | 1 |
| 2026-12-31 | $0.04 | $0.05 | $0.06 | 1 |
| 2027-03-31 | $0.04 | $0.05 | $0.06 | 1 |
| 2027-06-30 | $0.04 | $0.05 | $0.06 | 1 |
| 2027-09-30 | $0.05 | $0.06 | $0.08 | 1 |
| 2027-12-31 | $0.04 | $0.05 | $0.06 | 1 |
| 2028-12-31 | $0.20 | $0.50 | $1.01 | 3 |
| 2029-12-31 | $0.82 | $0.90 | $1.00 | 1 |
| 2030-12-31 | $0.93 | $1.01 | $1.12 | 1 |
Frequently Asked Questions
What is the analyst consensus for ALVO?
The consensus among 2 analysts covering Alvotech (ALVO) is Hold with an average price target of $8.33.
What is the highest price target for ALVO?
The highest price target for ALVO is $22.00, set by Balaji Prasad at Barclays on 2024-05-24.
What is the lowest price target for ALVO?
The lowest price target for ALVO is $5.00, set by Glen Santangelo at Barclays on 2025-12-08.
How many analysts cover ALVO?
2 analysts have issued ratings for Alvotech in the past 12 months.
Is ALVO a buy or sell right now?
Based on 2 analyst ratings, ALVO has a consensus rating of Hold (3.00/5) with a +105.0% upside to the consensus target of $8.33.
What are the earnings estimates for ALVO?
Analysts estimate ALVO will report EPS of $-0.02 for the period ending 2026-06-30, with revenue estimated at $132M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.